Publications

Home/Publications/

March 2020

Hepatic stellate cell hypertrophy is associated with metabolic liver fibrosis

By |2020-11-18T16:42:00+01:00March 4, 2020|

Sci Rep. 2020 Mar 2;10(1):3850. doi: 10.1038/s41598-020-60615-0.
Hepatic fibrosis is a major consequence of chronic liver disease such as non-alcoholic steatohepatitis which is undergoing a dramatic evolution given the obesity progression worldwide, and has no treatment to date...

February 2020

January 2020

Autophagy inhibition blunts PDGFRA adipose progenitors’ cell-autonomous fibrogenic response to high-fat diet

By |2020-11-18T16:56:00+01:00January 30, 2020|

Autophagy. 2020 Jan 28:1-11. doi: 10.1080/15548627.2020.1717129.
Adipose tissue (AT) fibrosis in obesity compromises adipocyte functions and responses to intervention-induced weight loss...

Gut Microbiota Profile of Obese Diabetic Women Submitted to Roux-en-Y Gastric Bypass and Its Association with Food Intake and Postoperative Diabetes Remission

By |2020-11-18T16:28:40+01:00January 25, 2020|

Nutrients. 2020 Jan 21;12(2):278. doi: 10.3390/nu12020278.
Gut microbiota composition is influenced by environmental factors and has been shown to impact body metabolism. Objective: To assess the gut microbiota profile before and after Roux-en-Y gastric bypass (RYGB) and the correlation with food intake and postoperative type 2 diabetes remission (T2Dr)...

OBEDIS Core Variables Project: European Expert Guidelines on a Minimal Core Set of Variables to Include in Randomized, Controlled Clinical Trials of Obesity Interventions

By |2020-11-18T16:39:02+01:00January 17, 2020|

Obes Facts. 2020;13(1):1-28. doi: 10.1159/000505342. Epub 2020 Jan 16.
Heterogeneity of interindividual and intraindividual responses to interventions is often observed in randomized, controlled trials for obesity. To address the global epidemic...

October 2019

Gut microbiota of obese subjects with Prader-Willi syndrome is linked to metabolic health

By |2020-11-18T17:25:18+01:00October 16, 2019|

Gut. 2020 Jul;69(7):1229-1238. doi: 10.1136/gutjnl-2019-319322.
The gut microbiota has been implicated in the aetiology of obesity and associated comorbidities. Patients with Prader-Willi syndrome (PWS) are obese but partly protected against insulin resistance...

June 2019

May 2019

April 2019

Phosphatidylglycerols are induced by gut dysbiosis and inflammation, and favorably modulate adipose tissue remodeling in obesity

By |2019-05-21T17:29:42+02:00April 11, 2019|

FASEB J. 2019 Apr;33(4):4741-4754
Lipidomic techniques can improve our understanding of complex lipid interactions that regulate metabolic diseases. Here, a serum phospholipidomics ...

Synergistic convergence of microbiota-specific systemic IgG and secretory IgA

By |2019-05-21T17:29:01+02:00April 1, 2019|

J. Allergy Clin. Immunol. 2019 Apr;143(4):1575-1585.e4
BACKGROUND: Commensals induce local IgA responses essential to the induction of tolerance to gut microbiota, but it remains unclea...

March 2019

February 2019

January 2019

November 2018

September 2018

[Monitoring adherence after weight loss surgery: Identifying factors leading to non-adherence in a cohort of 207 severely obese patients who have undergone surgery. An evaluation of severely obese patients’ adherence following weight loss surgery.]

By |2019-05-21T17:27:23+02:00September 1, 2018|

Rech Soins Infirm 2018 Sep;(134):70-77
Obese patients are increasingly being offered weight loss surgery, the success of which depends in part on the quality of a long-term follow-up aft...

August 2018

Go to Top